Striving for better access to care
The Novo Nordisk Haemophilia Foundation (NNHF) is a grant-making, non-profit organisation dedicated to improving access to care for people with haemophilia and allied disorders in low- and middle-income countries.
NNHF is driven by its vision that all people with haemophilia and allied disorders access care and treatment, wherever they live.
Established in 2005 in Zurich, Switzerland, the NNHF is mainly funded by Novo Nordisk while also receiving donations from other organisations and private benefactors, 100% of which are allocated to projects.
The NNHF funds projects to build capacity for diagnosis and care, encouraging its partners to join forces for sustainable impact and systemic change. Together, we strive to empower people with haemophilia and allied disorders to raise awareness, advocate with a united voice and live full lives.